| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |